WELCOME TO ASLMS 2016 |
|
March 31, 2016
Thank you for reading the Dermatology Times Maui Derm 2016 conference e-newsletter.
Click to see all our coverage.
|
ASLMS highlights |
|
Highlights of dermatology news in 2014 include promising data about nivolumab (Opdivo, Bristol-Myers Squibb) for melanoma and a new class of drugs that may help patients with stubborn cases of alopecia areata, a top dermatologist told attendees at the Maui Derm 2015 meeting Monday. Research to know about |
|
Psoriasis isn't always just a skin disease, dermatologists learned at the Maui Derm 2015 conference this week. Physicians are becoming increasingly aware that severe cases of psoriasis are indications of dangerous systemic inflammation. Newer drugs make a difference |
|
|
We welcome your feedback!
Please send your comments to:
Heather Onorati
Content Channel Director
Dermatology Times
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Dermatology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
